Skip to main content
Figure 4 | Journal of Translational Medicine

Figure 4

From: Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

Figure 4

Expression of surface molecules by patients' dendritic cells. Flow cytometric characterization of pertinent membrane molecules expressed by normal MDCs (n = 4; open columns) and cells from melanoma patients (n = 6): IDCs (light shade), MDCs (medium shade) and electrotransfected MDCs (dark shade; for CD83 and CD86, n = 6; other molecules were measured in the cells from Patient 1 and Patient 5 only). Shown are mean values ± standard deviation.

Back to article page